9
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Consequences of Increasing Time to Colonoscopy Examination Following Positive Result From Fecal Colorectal Cancer Screening Test

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          BACKGROUND & AIMS

          Delays in diagnostic testing after a positive result from a screening test can undermine the benefits of colorectal cancer (CRC) screening, but there are few empirical data on the effects of such delays. We used microsimulation modeling to estimate the consequences of time to colonoscopy following a positive result from a fecal immunochemical test (FIT).

          METHODS

          We used an established microsimulation model to simulate an average-risk United States population cohort that underwent annual FIT screening (from ages 50 to 75 years), with follow-up colonoscopy examinations for individuals with positive results (cutoff, 20 μg/g) at different time points in the following 12 months. Main evaluated outcomes were CRC incidence and mortality; additional outcomes were total life-years lost and net costs of screening.

          RESULTS

          For individuals who underwent diagnostic colonoscopy within 2 weeks of a positive result from a FIT, the estimated lifetime risk of CRC incidence was 35.5/1000 persons and mortality was 7.8/1000 persons. Every month added until colonoscopy was associated with a 0.1/1000 person increase in cancer incidence risk (an increase of 0.3%/month, compared with individuals who received colonoscopies within 2 weeks) and mortality risk (increase of 1.4%/month). Among individuals who received colonoscopy examinations 12 months after a positive result from a FIT, the incidence of CRC was 27.0/1000 persons (increase of 4%, compared with 2 weeks) and mortality was 9.1/1000 persons (increase of 16%). Total years of life gained for the entire screening cohort decreased from an estimated 93.7/1000 persons with an almost immediate follow-up colonoscopy (cost savings of $208 per patient, compared with no colonoscopy), to 84.8/1000 persons with follow-up colonoscopies at 12 months (decrease of 9%; cost savings of $100/patient, compared with no colonoscopy).

          CONCLUSION

          Using a microsimulation model of an average-risk US screening cohort, we estimated that delays of up to 12 months after a positive result from a FIT can produce proportional losses of up to nearly 10% in overall screening benefits. These findings indicate the importance of timely follow-up colonoscopy examinations of patients with positive results from FITs.

          Related collections

          Author and article information

          Journal
          101160775
          31839
          Clin Gastroenterol Hepatol
          Clin. Gastroenterol. Hepatol.
          Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
          1542-3565
          1542-7714
          26 May 2016
          19 May 2016
          October 2016
          01 October 2017
          : 14
          : 10
          : 1445-1451.e8
          Affiliations
          [1 ]Department of Public Health, Erasmus MC University Medical Center, Rotterdam, Netherlands
          [2 ]Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, United States
          [3 ]Department of Family Medicine and Community Health in the Perelman School of Medicine, Department of Epidemiology in the Perelman School of Medicine, and the Leonard Davis Institute of Health Economics and Center for Public Health Initiatives, University of Pennsylvania, Philadelphia, PA, United States
          [4 ]Kaiser Permanente Division of Research, Oakland, CA, United States
          [5 ]Kaiser Permanente Southern California, Research & Evaluation, Pasadena, CA, United States
          [6 ]Veterans Affairs Portland Healthcare System, Portland, OR, United States
          [7 ]Veterans Affairs Puget Sound Healthcare System, Seattle, WA, United States
          [8 ]Division of Gastroenterology, University of Washington School of Medicine, Seattle, Washington, USA
          Author notes
          CORRESPONDENCE: Reinier Meester, Department of Public Health, Erasmus MC University Medical Center, P.O. Box 2040, 3000 CA Rotterdam, The Netherlands. r.meester@ 123456erasmusmc.nl . Tel: +31-6-23 74 79 74. Fax: +31-10-703 84 75
          Article
          PMC5028249 PMC5028249 5028249 nihpa788666
          10.1016/j.cgh.2016.05.017
          5028249
          27211498
          350cb87f-285a-4542-aa4f-e6406159068f
          History
          Categories
          Article

          Screening and Early Detection,Occult Blood,Time Factors,Colorectal Neoplasms

          Comments

          Comment on this article